In light of the new EU regulation affecting the development and use of NIBS technology, Walter Paulus (LMU-KUM) moderated a roundtable with speakers voicing the perspectives of researchers, clinicians, patients, ethics boards and the industry, as well as a representative of the EC and Portuguese Regulatory Body.